-+ 0.00%
-+ 0.00%
-+ 0.00%

TONIX PHARMACEUTICALS ANNOUNCES LICENSING TNX-4900, A SELECTIVE SIGMA-1 RECEPTOR ANTAGONIST FOR CHRONIC NEUROPATHIC PAIN FROM RUTGERS UNIVERSITY

路透·12/16/2025 12:00:01

登錄查看新聞詳情